| [1] | SCHELTEN P, De STROOPE B, KIVIPELTO M, et al. Alzheimer's disease[J]. The Lancet, 2021, 397(10284):1577-1590. doi: 10.1016/S0140-6736(20)32205-4 |
| [2] | KIM A Y, JERDI S A, MACDONALD R, et al. Alzheimer’s disease and its treatment-yesterday, today, and tomorrow[J]. Front Pharmacol, 2024, 15:1399121. doi: 10.3389/fphar.2024.1399121 |
| [3] | YAN H Y, FENG L N, LI M Q. The role of traditional Chinese medicine natural products in β-amyloid deposition and tau protein hyperphosphorylation in Alzheimer’s disease[J]. Drug Des Devel Ther, 2023, 17:3295-3323. doi: 10.2147/DDDT.S380612 |
| [4] | 郭凤, 郝蕊, 陈鹏德, 等. 基于肠道菌群和肠黏膜屏障探讨玉液汤防治气阴两虚证糖尿病肾病大鼠的作用研究[J]. 世界科学技术-中医药现代化, 2024, 26(05):1308-1319. |
| [5] | 国家药典委员会. 中华人民共和国药典-二部: 2020年版[M]. 北京: 中国医药科技出版社, 2020: 329-527. |
| [6] | 韩莉花, 袁欣, 杨真儿, 等. 葛根知母药对调控HMGB1/RAGE/NF-κB通路改善糖尿病大鼠认知障碍[J]. 中药药理与临床, 2020, 36(1):124-130. |
| [7] | LIU X, HUANG R, WAN J Y. Puerarin: a potential natural neuroprotective agent for neurological disorders[J]. Biomed Pharmacother, 2023, 162:114581. doi: 10.1016/j.biopha.2023.114581 |
| [8] | ZHANG Q, YAN Y P. The role of natural flavonoids on neuroinflammation as a therapeutic target for Alzheimer’s disease: a narrative review[J]. Neural Regen Res, 2023, 18(12):2582-2591. doi: 10.4103/1673-5374.373680 |
| [9] | CHEN W Y, LI R T, ZHU S Q, et al. Nasal timosaponin BII dually sensitive in situ hydrogels for the prevention of Alzheimer’s disease induced by lipopolysaccharides[J]. Int J Pharm, 2020, 578:119115. doi: 10.1016/j.ijpharm.2020.119115 |
| [10] | CHUNG Y, LEE H, INITIATIVE T A D N. Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization[J]. Sci Rep, 2021, 11(1):15265. doi: 10.1038/s41598-021-94048-0 |
| [11] | ZHAI W J, ZHAO M, WEI C X, et al. Obesity-induced chronic low-grade inflammation in adipose tissue: a pathway to Alzheimer’s disease[J]. Ageing Res Rev, 2024, 99:102402. doi: 10.1016/j.arr.2024.102402 |
| [12] | KELLER J N. Age-related neuropathology, cognitive decline, and Alzheimer’s disease[J]. Ageing Res Rev, 2006, 5(1):1-13. doi: 10.1016/j.arr.2005.06.002 |
| [13] | FIRDAUS Z, SINGH N, PRAJAPATI S K, et al. Centella asiatica prevents D-galactose-Induced cognitive deficits, oxidative stress and neurodegeneration in the adult rat brain[J]. Drug Chem Toxicol, 2022, 45(3):1417-1426. doi: 10.1080/01480545.2020.1833907 |
| [14] | TYCZYŃSKA M, GĘDEK M, BRACHET A, et al. Trace elements in Alzheimer’s disease and dementia: the current state of knowledge[J]. J Clin Med, 2024, 13(8):2381. doi: 10.3390/jcm13082381 |
| [15] | CHIROMA S M, MOHD MOKLAS M A, MAT TAIB C N, et al. D-galactose and aluminium chloride induced rat model with cognitive impairments[J]. Biomedecine Pharmacother, 2018, 103:1602-1608. doi: 10.1016/j.biopha.2018.04.152 |
| [16] | LIU P, YANG Q, YU N, et al. Phenylalanine metabolism is dysregulated in human hippocampus with Alzheimer’s disease related pathological changes[J]. J Alzheimers Dis, 2021, 83(2):609-622. doi: 10.3233/JAD-210461 |
| [17] | YAO Y X, HAN W P. Proline metabolism in neurological and psychiatric disorders[J]. Mol Cells, 2022, 45(11):781-788. doi: 10.14348/molcells.2022.0115 |
| [18] | XU X J, DING Y, LIU M H, et al. Neuroprotective mechanisms of defatted walnut powder against scopolamine-induced Alzheimer’s disease in mice revealed through metabolomics and proteomics analyses[J]. J Ethnopharmacol, 2024, 319(Pt 1): 117107. |
| [19] | XU M T, LIU D, WANG L L. Role of oxylipins in ovarian function and disease: a comprehensive review[J]. Biomed Pharmacother, 2024, 178:117242. doi: 10.1016/j.biopha.2024.117242 |
| [20] | SHAO Y P, OUYANG Y, LI T B, et al. Alteration of metabolic profile and potential biomarkers in the plasma of Alzheimer’s disease[J]. Aging Dis, 2020, 11(6):1459-1470. doi: 10.14336/AD.2020.0217 |
| [21] | 周玲, 刘颖, 贡盈歌, 等. 阿尔茨海默病模型小鼠脑组织生物标记物代谢组学分析[J]. 沈阳药科大学学报, 2016, 33(6):459-465. |
| [22] | JOMOVA K, ALOMAR S Y, ALWASEL S H, et al. Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants[J]. Arch Toxicol, 2024, 98(5):1323-1367. doi: 10.1007/s00204-024-03696-4 |
| [23] | SEIDITA A, CUSIMANO A, GIULIANO A, et al. Oxidative stress as a target for non-pharmacological intervention in MAFLD: could there be a role for EVOO?[J]. Antioxidants, 2024, 13(6):731. doi: 10.3390/antiox13060731 |